Page 6 of lupin

Lupin, Lupin Limited, generic formulations, sleep disorders, healthcare news,

USFDA gives tentative approval to Lupin’s generic formulation to treat excessive daytime sleepiness

Lupin is exclusive first-to-file and may be eligible to receive a 180-day exclusivity period at product launch, the company stated.

October 13, 2023 12:50 IST

USFDA gets tentative approval for tablets to treat low sodium levels in heart patients

This product will be manufactured at Lupin’s Nagpur facility in India.

October 6, 2023 11:18 IST

Lupin launches patient support program for diabetes management

Individuals living with the illness are at increased risk of developing multiple complications, including heart disease, stroke, kidney ailments, nerve…

October 4, 2023 14:12 IST

Lupin gets EIR from USFDA for its Nagpur Unit-1 Manufacturing Facility

The U.S. FDA has determined that the inspection classification of the facility is Voluntary Action Indicated (VAI).

September 29, 2023 15:54 IST

Lupin acquires five brands from Menarini to strengthen its therapy portfolio in India

“This strategic acquisition for the Indian market marks a significant step forward for Lupin as it continues to expand its…

September 22, 2023 14:28 IST

Lupin gets USFDA approval for its chronic lung disorder capsules

Pirfenidone Capsules (RLD Esbriet) had estimated annual sales of USD 95 million in the U.S. (IQVIA MAT June 2023).

August 31, 2023 10:13 IST

CDSCO, drug alert, DCGI, spurious drugs, drug quality, healthcare news, pharma news

Lupin acquires brands from Boehringer Ingelheim to expand Diabetes portfolio in India

This acquisition strengthens Lupin’s commitment to providing superior treatment options for patients navigating the complexities of diabetes, it claimed.

August 18, 2023 15:51 IST

Lupin Launches inhaler powder for COPD in the United States

Tiotropium Bromide Inhalation Powder (Reference Product Spiriva HandiHaler) had estimated annual sales of USD 1,264 million in the US (IQVIA…

August 18, 2023 08:00 IST

Lupin gets USFDA nod for its anti-inflammatory eye drop

This product will be manufactured at Lupin’s Pithampur facility in India.

August 17, 2023 08:00 IST

USFDA approves Lupin’s extended-release tablets to treat chest pain

According to the company’s press statement, the approval is to market a generic equivalent of Toprol-XL Tablets, 25 mg, 50…

August 17, 2023 07:00 IST

Lupin posts Q1 profit at Rs 453.33 crore against year-ago loss, reports growth across all key markets

Lupin posted revenue from operations at Rs 4814.06 core, up 28.6 per cent in comparison to Rs 3743.84 crore during…

August 4, 2023 13:04 IST

Lupin gets approval from TGA Australia for drug to treat COPD

Tiotropium Bromide Inhalation Powder (Reference Product Spiriva) had estimated annual sales of USD 10 million in Australia (IQVIA MAT Mar…

July 27, 2023 06:33 IST

Lupin gets EIR from USFDA for its Pithampur Unit-2 Manufacturing Facility

The EIR was issued post the last inspection of the facility conducted from March 21 to March 29, 2023.

July 12, 2023 08:00 IST

Pharma major Lupin, Atharv Ability, Neuro-rehabilitation, Neurological disorders, healthcare news,

‘Patients with neurological disorders need comprehensive care and rehabilitation facilities’

According to WHO estimates, only 5%–15% of disabled individuals in LMICs have access to assistive devices.

July 10, 2023 08:00 IST

Lupin, Lupin Limited, HIV/AIDS, drugs, generic drugs, healthcare news, pharma news,

USFDA gives tentative approval to Lupin’s HIV/AIDS drug

This product will be manufactured at Lupin’s Nagpur facility in India.

July 4, 2023 17:15 IST

USFDA gives nod to Lupin’s nasal spray for Vitamin B12 deficiency

Cyanocobalamin is a form of vitamin B12 used to treat vitamin B12 deficiency.

July 3, 2023 17:12 IST

Lupin Digital Health, Lupin Limited, digital therapeutics, healthcare news,

FE Exclusive | We intend to cover 70-80% of cardiologists, increase partnerships with hospitals: Sidharth Srinivasan, CEO, Lupin Digital Health

Srinivasan also highlighted the company’s role in cardiac care, upcoming business plans, role and importance of DTx in India, and…

June 24, 2023 10:00 IST

Lupin launches oral suspension for treatment of seizure disorder in United States

Rufinamide Oral Suspension (RLD Banzel) had estimated annual sales of USD 72 million in the U.S. (IQVIA MAT April 2023).

June 23, 2023 13:32 IST

Related News

Aadhaar Card update October 2025: Here’s how to change name, address, date of birth and phone number online in simple steps

‘India proved everyone wrong’: IMF chief hails bold reforms, says country ’emerging as key engine of global growth’

What is SB 509? Controversial ‘anti-India’ bill vetoed by California Gov Newsom

Canara Robeco AMC Share Price today, October 16

LIVE: Will Canara Robeco IPO deliver a listing pop? Check why GMP is surging

US visa rules, US visa policy, immigrant visa interview, nonimmigrant visa update, consular district interview, US embassy visa process, visa scheduling changes 2025, US travel regulations

US announces stricter visa interview rules for all immigrant and nonimmigrant applicants

Markets trending higher: Nifty near 25,400, Sensex rises 270 points; Axis Bank up 3%

Market28 min ago

Indices opened higher, with NSE Nifty 50 and BSE Sensex rising 0.29% and 0.33%, respectively. Bank Nifty also opened higher, along with small and midcap stocks. The US administration’s comments hint at a possible trade deal with India, given China’s actions. Indian macros remain strong, but exports and jobs in labour-intensive areas have been hit. Technical analysis suggests a bullish momentum.

View all shorts